SUDO BIOSCIENCES
Sudo Biosciences is a biopharmaceutical company that designs and develops medicines that target the tyrosine kinase 2 (TYK2) pseudokinase domain, a crucial mediator in cytokine signaling pathways that have been linked to a broad range of immune-mediated inflammatory conditions. Its pipeline of next-generation TYK2 inhibitors includes a potential brain-penetrant candidate for treating multiple sclerosis and neurodegenerative diseases with underlying neuroinflammation and a potential topical candidate for immune-mediated dermatologic diseases. It helps patients receive the cure or the treatment of multiple sclerosis and neurodegenerative diseases with underlying neuroinflammation at a competitive cost.
SUDO BIOSCIENCES
Social Links:
Industry:
Biopharma Biotechnology Health Care Life Science Medical
Founded:
2020-01-01
Address:
Carmel, Indiana, United States
Country:
United States
Website Url:
http://www.sudobio.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
183 M USD
Technology used in webpage:
Font Awesome Mobile Non Scaleable Content ReCAPTCHA U.S. Server Location Java EE GoDaddy SSL Visa MasterCard American Express
Similar Organizations
MapLight Therapeutics
MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Coriell Life Sciences
Coriell Life Sciences delivers the power of precision medicine using pharmacogenomics and clinical decision support software.
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
FogPharma
FogPharma creates a new class of medicines that target human disease drivers currently considered undruggable.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Ocean Biomedical
Ocean Biomedical is a biotechnology company that accelerates new discoveries in the world of medicine.
Current Advisors List
Current Employees Featured
Founder
Investors List
Leaps by Bayer
Leaps by Bayer investment in Series B - Sudo Biosciences
Velosity Capital
Velosity Capital investment in Series B - Sudo Biosciences
Frazier Life Sciences
Frazier Life Sciences investment in Series B - Sudo Biosciences
Dementia Discovery Fund
Dementia Discovery Fund investment in Series B - Sudo Biosciences
UPMC Enterprises
UPMC Enterprises investment in Series B - Sudo Biosciences
Monograph Capital
Monograph Capital investment in Series B - Sudo Biosciences
Surveyor Capital
Surveyor Capital investment in Series B - Sudo Biosciences
Sanofi Ventures
Sanofi Ventures investment in Series B - Sudo Biosciences
TPG
TPG investment in Series B - Sudo Biosciences
Eventide
Eventide investment in Series B - Sudo Biosciences
Key Employee Changes
| Date | New article |
|---|---|
| 2022-10-10 | Sudo Biosciences Appoints Imran Babar, Ph.D., as Chief Business Officer |
Official Site Inspections
http://www.sudobio.com Semrush global rank: 5.59 M Semrush visits lastest month: 1.29 K
- Host name: ec2-54-176-110-96.us-west-1.compute.amazonaws.com
- IP address: 54.176.110.96
- Location: San Jose United States
- Latitude: 37.3388
- Longitude: -121.8914
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95141
More informations about "Sudo Biosciences"
Sudo Biosciences - Crunchbase Company Profile
Sudo Biosciences is a biopharma company that designs and develops medicines that target the tyrosine kinase 2 (TYK2) pseudokinase domain.See details»
Sudo Biosciences Company Profile - Office Locations ... - Craft
Sudo Biosciences has 5 employees at their 1 location and $153 m in total funding,. See insights on Sudo Biosciences including office locations, competitors, revenue, financials, executives, …See details»
Sudo Biosciences: Contact Details and Business Profile
Sudo Biosciences is a Biotechnology Research company_reader located in Carmel, Indiana with 18 employees. Find top employees, contact details and business statistics at RocketReach.See details»
Sudo Biosciences 2025 Company Profile: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for Sudo Biosciences. Use the PitchBook Platform to explore the full profile.See details»
Sudo Biosciences Company Profile | Management and Employees …
Sudo Biosciences Profile and History Founded in 2020 and headquartered in Menlo Park, California, Sudo Biosciences is a biopharmaceutical company.See details»
Sudo Biosciences (USA) Funding: $183M - Medical Startups
Mar 27, 2025 USA | Funding: $183M (+) Website: https://www.sudobio.com Sudo Biosciences is a biopharmaceutical company committed to developing cutting-edge medications that are …See details»
Sudo Biosciences - Products, Competitors, Financials, Employees ...
About Sudo Biosciences Sudo Biosciences designs and develops medicines. The company's main offerings include the development of therapeutics targeting the tyrosine kinase 2 (TYK2) …See details»
Sudo Biosciences - VentureRadar
"Sudo Biosciences is a biopharmaceutical company that specializes in designing and developing novel medicines to transform patients’ lives. The firm's primary focus is on the tyrosine kinase …See details»
Sudo Biosciences, Inc. - Golden
Company attributes Industry Biotechnology Location Menlo Park, California San Francisco Legal Name Sudo Biosciences, Inc. Legal classification Corporation Date Incorporated 2020 CIK …See details»
Sudo Biosciences - 2025 Company Profile - Tracxn
Mar 22, 2025 Sudo Biosciences - Developer of therapeutics for immune-mediated inflammatory conditions. Raised a total funding of $183M over 3 rounds from 14 investors.See details»
Leaps by Bayer
Approach Sudo Biosciences is committed to designing and developing novel medicines to transform patients’ lives. The lead programs target the tyrosine kinase 2 (TYK2) pseudokinase …See details»
Sudo Biosciences Raises $116M Series B Financing to Advance
Dec 20, 2023 For more information, visit www.sudobio.com. Enavate Sciences is a portfolio company of Patient Square Capital dedicated to supporting therapeutic companies advancing …See details»
Sudo Biosciences - Overview, News & Similar companies - ZoomInfo
Oct 15, 2022 View Sudo Biosciences (www.sudobio.com) location in Indiana, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Sudo Biosciences Raises $116M Series B Financing to ... - Enavate …
Dec 20, 2023 Both candidates are anticipated to enter clinical trials in 2024. Sudo Biosciences is based in Carmel, IN, with operations across the US and UK. For more information, visit …See details»
In the News | Articles for Sudo Biosciences
Dec 20, 2023 Latest News Articles for Sudo Biosciences, a biopharmaceutical company committed to designing and developing novel, best-in-class medicines to transform patients’ lives.See details»
Sudo Biosciences - VentureRadar
Sudo Biosciences is a biopharmaceutical company focused on designing and developing medicines to improve patients’ lives. The company’s programs target the tyrosine kinase 2 …See details»
Series B - Sudo Biosciences - 2024-02-13 - Crunchbase
Feb 13, 2024 sudobio.com — Sudo Biosciences Announces Second Close of Upsized Series B Financing Bringing Total Raised in Round to $147MSee details»
BMS was first but startup Sudo Bio aims to be best at blocking key ...
Oct 2, 2022 Sudo Bioscience emerged with $37 million in funding and four programs that address TYK2, a promising target for autoimmune diseases. Bristol Myers Squibb drug …See details»
Sutro Biopharma Announces Strategic Portfolio Review Resulting …
Mar 13, 2025 Astellas: Two research and development programs are ongoing with Astellas for dual-payload immunostimulatory ADCs (iADCs). These collaborations remain a strategic …See details»
Latest News for Sudo Biosciences
Latest News for Sudo Biosciences, a biopharmaceutical company committed to designing and developing novel, best-in-class medicines to transform patients’ lives.See details»